Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.

Pattacini L, Mize GJ, Graham JB, Fluharty TR, Graham TM, Lingnau K, Wizel B, Perdiguero B, Esteban M, Pantaleo G, Shen M, Spies GA, McElrath MJ, Lund JM.

PLoS One. 2012;7(7):e42163. doi: 10.1371/journal.pone.0042163. Epub 2012 Jul 25.

2.

Adjuvants: tailoring humoral immune responses.

McElrath MJ.

Curr Opin HIV AIDS. 2017 May;12(3):278-284. doi: 10.1097/COH.0000000000000365. Review.

PMID:
28257301
3.

Immune mechanisms of protection: can adjuvants rise to the challenge?

McKee AS, MacLeod MK, Kappler JW, Marrack P.

BMC Biol. 2010 Apr 12;8:37. doi: 10.1186/1741-7007-8-37. Review.

4.

T cell vaccinology: exploring the known unknowns.

Burchill MA, Tamburini BA, Pennock ND, White JT, Kurche JS, Kedl RM.

Vaccine. 2013 Jan 2;31(2):297-305. doi: 10.1016/j.vaccine.2012.10.096. Epub 2012 Nov 6. Review.

5.

The influence of delivery vectors on HIV vaccine efficacy.

Ondondo BO.

Front Microbiol. 2014 Aug 22;5:439. doi: 10.3389/fmicb.2014.00439. eCollection 2014. Review.

6.

Cell-mediated immunologic memory in prevention and treatment of HIV disease.

Salk PL, Salk J.

Res Immunol. 1994 Oct-Dec;145(8-9):629-33; discussion 634-5. Review. No abstract available.

PMID:
7754212
7.

New concepts in HIV-1 vaccine development.

Stephenson KE, D'Couto HT, Barouch DH.

Curr Opin Immunol. 2016 Aug;41:39-46. doi: 10.1016/j.coi.2016.05.011. Epub 2016 Jun 3. Review.

Supplemental Content

Support Center